Our Expert in Greece
No results available
IPI public procurement Greece is now firmly on the agenda, as the European Commission’s 2026 review of the International Procurement Instrument (IPI) reopens questions about how third-country access to EU public contracts is managed, how innovation is bought, how public-private partnerships are structured, and how Greek contracting authorities and bidders must prepare. The Commission’s consultation under its Better Regulation framework runs until 1 December 2026, giving stakeholders a limited window to shape the outcome. For Greece, where major tenders, privatisations and PPPs flow through the Hellenic Republic Asset Development Fund (now part of the Hellenic Corporation of Assets and Participations, HCAP/HRADF) and a network of contracting authorities, the practical stakes are significant.
This article explains what the review covers, what could change, and what authorities, PPP sponsors and bidders should consider now.
Note on terminology: at EU level, “IPI” formally refers to the International Procurement Instrument established by Regulation (EU) 2022/1031, which addresses reciprocal access for third-country economic operators to EU public procurement markets. This article uses “IPI public procurement Greece” as its focus keyword while also addressing the broader innovation-procurement and PPP context relevant to Greek stakeholders.
Who this is for: Greek contracting authorities, in-house counsel, PPP sponsors and bidders. For a broader view, see our Public Procurement, Greece practice-area overview and the Global Law Experts lawyer directory for Greece: Public Procurement.
The IPI review is the European Commission’s examination of the scope, functioning and efficiency of the International Procurement Instrument and, more broadly, of the EU’s tools for shaping access to and innovation in public buying. Conducted through the Commission’s Better Regulation / Have Your Say consultation process, the review invites evidence from member states, contracting authorities, industry and civil society. The consultation period is open until 1 December 2026. Its headline objective is to assess whether the current rules and instruments deliver value, promote reciprocity and genuine innovation, and remain administratively workable, and, where they do not, to consider adjustments.
For anyone following IPI public procurement Greece, the central point is this: the review is a diagnostic exercise with potential downstream effects on how national tenders are designed and evaluated. Depending on the Commission’s conclusions, the outcome could range from non-binding guidance to proposals for legislative change. Either path would eventually touch Greek practice, because national procurement rules sit within the EU framework.
Innovation procurement in the EU is anchored in Directive 2014/24/EU on public procurement. That directive introduced the innovation partnership procedure and set out the award-criteria architecture, including the most economically advantageous tender (MEAT) concept, that allows authorities to reward quality, lifecycle cost and innovative characteristics rather than price alone. Pre-commercial procurement, by contrast, operates largely outside the directive’s full procurement regime where research and development services are shared between purchaser and supplier, enabling early-stage innovation buying.
Utilities and many infrastructure-type arrangements can fall under Directive 2014/25/EU on utilities procurement, which matters directly for PPPs in sectors such as water, energy and transport. In Greece, these directives are transposed principally through Law 4412/2016 on public works, supplies and services contracts (as amended, notably by Law 4782/2021), with concessions governed by Law 4413/2016. The directive-level baseline, as transposed into Greek law, is the reference point against which any IPI-driven change will be measured. The interpretation of these rules is shaped by the Court of Justice of the European Union, whose case law on award criteria, transparency and remedies remains authoritative for national courts and review bodies.
EU procurement rules are implemented and applied nationally. That means the practical effect of any IPI reform depends heavily on how each member state translates it into tender documents, evaluation methodologies and contract templates. The European Court of Auditors has examined the efficiency and implementation of EU procurement, and the OECD has published extensive evidence on innovation procurement as a tool for value and productivity. Both strands of analysis feed the policy debate that the IPI review will draw upon. For Greece, the review is an opportunity to flag where instruments have worked, where administrative friction has deterred use, and where clearer rules would unlock innovation in public buying.
No one can predict the exact output of the IPI review, and this section is necessarily framed in terms of what the review could address rather than what it will decide. That said, the structure of the consultation and the recurring themes in EU procurement policy suggest several likely areas of focus. Commentators expect the review to touch on several clusters: the scope and clarity of market-access and innovation instruments, the operation of innovation partnerships, the treatment of PPP-style procurement, and the interaction with state-aid and competition law.
The two workhorses of EU innovation buying are innovation partnerships and pre-commercial procurement. Innovation partnerships, under Directive 2014/24/EU, allow an authority to contract for both the development and the subsequent purchase of an innovative solution within a single procedure structured into successive phases. Pre-commercial procurement sits upstream, focusing on competitive R&D before any commercial roll-out. The review may seek to simplify these instruments, clarify when each should be used, and reduce the administrative burden that practitioners frequently cite as a barrier to uptake.
| Area | Current EU / national approach | Possible change under review | Practical impact for Greece |
|---|---|---|---|
| Innovation partnerships | Multi-phase procedure under Directive 2014/24/EU; development and purchase combined | Possible simplification and clearer phase-gate guidance | Simpler templates could increase use by Greek authorities |
| Pre-commercial procurement | Sits largely outside full directive regime; shared R&D risk | Clearer scoping of what qualifies and how to structure it | More confident early-stage buying by Greek bodies |
| Award criteria | MEAT framework; lifecycle cost and quality permitted | Potential guidance on scoring innovation outcomes | Evaluation templates in Greece may need recalibration |
| Intellectual property | Allocation negotiated per contract | Possible default or model IP provisions | Standardised IP positions in Greek tenders |
| Third-country access / PPPs | IPI (Regulation (EU) 2022/1031) and national transposition of thresholds | Review of how IPI and innovation PPPs are treated | Possible impact on HRADF/HCAP-linked deals |
| Joint procurement | Permitted; cross-border and aggregated buying supported | Encouragement of aggregated innovation demand | Opportunities for Greek authorities to pool demand |
| Scalability | Scale-up often requires separate procurement | Possible smoother path from pilot to scale | Reduced re-tendering friction for proven solutions |
| Utilities / PPPs | Directive 2014/25/EU applies to utilities sectors | Clarified interface between instruments and utilities rules | Clearer routing for energy, water and transport PPPs |
| Market engagement | Preliminary market consultation permitted | Stronger endorsement and guidance on early engagement | More structured pre-tender dialogue in Greece |
| Remedies and transparency | CJEU case law and national review bodies govern interpretation | Possible clarification to reduce litigation risk | More predictable review outcomes for Greek tenders |
The comparison above is indicative. Each row reflects a plausible direction of travel rather than a confirmed reform, and the final shape will depend on the Commission’s assessment and any legislative follow-up. For those tracking IPI public procurement Greece, the table is most useful as a planning tool: it identifies the areas where tender documentation is most likely to require updating.
PPPs occupy a distinctive position because they combine long-term contracting, significant risk transfer and, often, an innovation or design component. In Greece, PPPs are additionally governed by Law 3389/2005, with projects assessed by the Inter-Ministerial PPP Committee and supported by the Special Secretariat for PPPs. Depending on the sector, a PPP may be procured under the general procurement rules, the utilities rules, or the concessions framework. The IPI review’s treatment of market access and innovation could ripple into PPP procurement where authorities seek novel technical solutions through phased or outcome-based procedures.
The likely practical effect, if the review encourages phased innovation buying, is that PPP tenders may increasingly build in pilot and scale-up stages, with payment triggers linked to demonstrated performance. That would place a premium on carefully drafted milestone, acceptance and change-management provisions. Competitive procedures, including the competitive procedure with negotiation and competitive dialogue, remain the natural home for complex PPPs, and any guidance that clarifies their use for innovation would be welcome to Greek contracting authorities handling technically ambitious projects.
Innovation procurement and PPPs do not sit in isolation from competition and state-aid law. Where an authority funds development or shares risk, questions of selective advantage and market distortion can arise. In Greece, this is especially relevant where procurement intersects with privatisation and asset-development processes managed through HRADF under the HCAP group. Any IPI-driven encouragement of risk-sharing or phased funding will need to be reconciled with state-aid discipline, and the review provides a chance to seek clarity on that interface. The prudent course for Greek stakeholders is to treat state-aid analysis as a parallel workstream in any innovation PPP, not an afterthought.
For contracting authorities, the consultation window is a reason to act, not to wait. Even before the Commission reports, authorities can position themselves to respond quickly to any new guidance and, in the meantime, strengthen their innovation procurement capability. The following steps structure that preparation across governance, evaluation, planning and institutional coordination.
Begin with internal procedures and standard tender documentation. Authorities should map which of their template clauses, on award criteria, IP, phasing, acceptance and remedies, would need revision under each plausible reform scenario in the comparison table above. Establishing a small cross-functional review group, combining procurement, legal and technical expertise, allows an authority to translate any new Commission guidance into updated templates efficiently. Documenting current practice also produces useful evidence for the consultation itself. In Greece, tender documentation and electronic procurement run through the national e-procurement systems (ESIDIS/Promitheus and KIMDIS), so template changes should be reflected there.
Award criteria are where innovation ambitions succeed or fail in practice. Under the MEAT framework in Directive 2014/24/EU (and Law 4412/2016), authorities can already reward quality, technical merit and lifecycle cost. The practical task is to design scoring methodologies that credibly reward innovation outcomes without becoming arbitrary or litigable. Authorities should:
Preliminary market consultation is permitted and underused. Early, structured engagement with the supplier market helps authorities understand what is technically feasible, calibrate requirements realistically, and avoid specifying solutions the market cannot deliver. Technology scouting, open market dialogues and requests for information all feed better tender design. If the IPI review strengthens the endorsement of early engagement, as many expect, authorities that already run disciplined market consultations will adapt fastest. The key discipline is transparency: engagement must not confer an unfair advantage on any participant, and records should demonstrate even-handed treatment.
Bodies that handle complex, high-value transactions, including HRADF (within the HCAP group) and dedicated PPP units, carry particular responsibility. These teams should review their standard transaction documents for innovation and phasing readiness, align their state-aid clearance workflows with any phased-funding approaches, and prepare to incorporate revised milestone and acceptance regimes. HRADF guidance and project materials are published on the HRADF official site, and keeping those aligned with evolving EU practice will reduce friction in future tenders.
What to do in the next 30 / 90 / 180 days:
Bidders and PPP sponsors face the mirror image of the authority’s task. If innovation instruments and PPP procedures evolve, the way offers are structured, priced and legally protected will need to change too. Proactive bidders can turn regulatory uncertainty into competitive advantage by building flexibility into their proposals now. The following checklist frames that work across technical, commercial, structural and compliance dimensions.
Flexible, phased offers are increasingly valuable where authorities buy innovation in stages. Bidders should prepare proposals that can accommodate pilot, proof-of-concept and scale-up phases, with clear deliverables at each gate. Where a procedure invites development followed by purchase, the technical offer should articulate how early-stage work translates into a scalable solution. Proof-of-concept clauses, acceptance criteria and demonstrable success metrics help authorities evaluate confidently and protect the bidder against moving targets later.
Risk allocation is where innovation procurement contracts most often go wrong. Bidders should pay close attention to:
Innovation partnerships and phased procedures often reward collaborative structures. Bidders may form consortia to combine R&D capability with delivery capacity, or to span the feasibility and scale-up stages of a project. The structure should allocate risk and reward coherently across members, address what happens if one member exits after a phase gate, and ensure that the lead entity holds the authority and governance to manage the contract. Clear liability positions, and well-drafted internal consortium agreements, protect both the bid and its delivery.
Compliance evidence is not a formality. Bidders should maintain robust documentation of eligibility, technical capacity and prior performance, and understand the remedies available if a tender is run unlawfully. In Greece, pre-contractual challenges are heard by the Single Independent Public Procurement Authority (which absorbed the former Authority for the Examination of Pre-Contractual Disputes, AEPP) and, ultimately, before the administrative courts and the Council of State. The CJEU case law accessible through the Court of Justice portal shapes how transparency and equal-treatment obligations are interpreted. Knowing the standstill and review mechanics before bidding, rather than after an adverse decision, is part of disciplined procurement compliance in Greece.
Recommended red lines for bidders: resist uncapped liability for innovation outcomes; refuse to transfer IP generated through co-funded development without fair compensation; and reject payment structures that place all development risk on the supplier before any acceptance gate. These positions are starting points for negotiation, not absolutes, but they help anchor commercial discussions.
Any EU-level change must be read against the Greek legal and institutional landscape. Greek procurement law (principally Law 4412/2016 and Law 4413/2016) transposes the EU directives, so a reform that alters the directive baseline would eventually require national adjustment; a reform delivered through guidance would influence practice without immediate legislative change. Understanding which route the Commission takes is therefore essential to timing the Greek response correctly.
If the IPI review produces legislative proposals, for example, adjustments to innovation-partnership procedures or new default provisions, Greek transposing legislation would need corresponding amendment. In the interim, contracting authorities can align their discretionary practice with the directive baseline while monitoring the Commission’s output. The safest position is to design tenders that remain compliant under current law while being adaptable to anticipated change.
HRADF’s role in privatisation and asset development places it at the intersection of procurement, competition and investment considerations. Where asset-development tenders carry an innovation or infrastructure component, any IPI-driven shift toward phased or outcome-based procurement would need to be reflected in HRADF’s transaction structures. Reviewing standard documents against the reform scenarios, and coordinating early with legal and state-aid advisers, positions HRADF-linked transactions to absorb change smoothly.
State-aid clearance and competition analysis should run in parallel with procurement design wherever public funding supports development or risk-sharing. The timing of state-aid approval can determine whether a PPP or innovation tender proceeds on schedule. Action items for HRADF and similar bodies include building state-aid checkpoints into transaction timelines, documenting the market-economy rationale for public contributions, and seeking clarity through the consultation on how innovation risk-sharing is treated under state-aid discipline.
Responding to the consultation is the single most direct way for Greek stakeholders to influence the outcome. Feedback is submitted through the Commission’s Have Your Say portal, where the specific IPI initiative entry sets out the questions and the submission mechanics. The window closes on 1 December 2026, so coordinating positions early is advisable.
Suggested focus points for different stakeholders:
Coordinated, evidence-based submissions carry more weight than generic comments. Stakeholders should align their positions where interests overlap and support each point with national practice. For a tailored compliance review and help preparing a consultation response, contact the Global Law Experts public procurement practice for Greece.
The 2026 IPI review will not transform IPI public procurement Greece overnight, but it signals the direction of EU procurement and PPP policy, and the consultation deadline of 1 December 2026 makes preparation urgent rather than optional. The organisations that act now will be best placed to adapt their tenders, bids and contracts quickly once the Commission reports. Use the checklist below as a starting point, and seek legal review on the areas specific to your transactions.
For a compliance review tailored to your tenders and PPPs, and for help shaping a consultation submission, contact the Global Law Experts public procurement practice for Greece.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Nikolas Avgouleas at Fortsakis Diakopoulos & Associates, a member of the Global Law Experts network.
posted 7 minutes ago
posted 10 minutes ago
posted 16 minutes ago
posted 16 minutes ago
posted 16 minutes ago
posted 16 minutes ago
posted 25 minutes ago
posted 33 minutes ago
posted 41 minutes ago
posted 45 minutes ago
posted 1 hour ago
posted 1 hour ago
No results available
Find the right Legal Expert for your business
Send welcome message